Manipal Health Enterprises (MANIPALHOS) — Financial Results

Investor Takeaways

Board approved unaudited Q1 FY2026 financial results

Dr. Hebri Sudarshan Ballal and Mr. Puneet Bhatia reappointed as directors

Shareholder approval required for TPG's proposed upside share payment to MRMSI

Overall Tone: Neutral based on the numbers only.

Key Financial Highlights

Metric	Value	YoY Change
Revenue	Not available	N/A
Net Profit	Not available	N/A
EBITDA	Not available	N/A
EPS	Not available
OPM	Not available

What Changed

The filing details governance updates rather than financial performance. The board reappointed Dr. Hebri Sudarshan Ballal and Mr. Puneet Bhatia as directors, reflecting continuity in leadership. Additionally, the Articles of Association were amended to add Article 99.1, which grants Temasek and MGHS Group the right to nominate directors contingent on shareholding thresholds. This structural change alters board composition protocols but does not impact current financial metrics. The 16th AGM is scheduled for September 29, 2026, where shareholder approval will be sought for TPG's proposed upside share payment to MRMSI. No financial results were disclosed in this announcement, and no quantitative changes to revenue, profit, or margins were reported.

Peer Comparison

Company	P/E	ROE	ROCE	Market Cap (₹ Cr)
Manipal Health Enterprises Limited	Not available	Not available	Not available	Not available
[Peer 1 — from provided peer data]
[Peer 2 — from provided peer data]

No specific peer comparison data was provided in the context.

Manipal Health Enterprises Limited's governance actions do not currently allow for quantitative peer benchmarking based on available information.

Risks & Concerns

Shareholder approval is required for TPG's proposed upside share payment to MRMSI, introducing potential implementation delays or rejection risk

Director reappointments were noted without performance commentary, but no governance concerns were raised in this filing

No specific risks related to financial performance or material weaknesses were identified in this filing.

Quarterly Trend

[This entire section is omitted because quarterly trend data was not provided in the context.]

📄 View Original Announcement (PDF)

📊 Stock Analysis — MANIPALHOS ✨ Ask AI About This

About Manipal Health Enterprises Limited (MANIPALHOS)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹98,258.68 Cr

View full MANIPALHOS stock details →

📡 Get AI alerts when MANIPALHOS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MANIPALHOS — Free

💡 Ask AI about this filing

"When will the unaudited Q1 FY2026 financial results be publicly available?" "What is the current shareholding percentage of Temasek Group to trigger director nomination rights?" "How will the upside share payment to MRMSI impact Company finances?"

Ask AI Free →

📊 More MANIPALHOS filings

See all MANIPALHOS filings →

🔥 Also filed on 20 August 2026

JSLL Jeena Sikho Lifecare Limited Financial Results ANURAS Anupam Rasayan India Limited Financial Results NIRAJ Niraj Cement Structurals Limited Announcement PNBHOUSING PNB Housing Finance Limited Corporate Action KRONOX Kronox Lab Sciences Limited Announcement SUPRAJIT Suprajit Engineering Limited Annual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MANIPALHOS files new disclosures

Track MANIPALHOS filings, board meetings, and corporate actions. Free email alerts at 5 PM.